Jun Qi
34Patents
9h-index
30Co-inventors
71Inventor score
Filing activity: May 16, 2011 → Nov 1, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9714946B2 | Bromodomain binding reagents and uses thereof | Physics | 33 | Active |
| US8981083B2 | Compositions and methods for treating neoplasia, inflammatory disease and other disorders | Emerging Cross-Sectional Technologies | 23 | Active |
| US9320741B2 | Compositions and methods for treating neoplasia, inflammatory disease and other disorders | Emerging Cross-Sectional Technologies | 21 | Active |
| US9301962B2 | Male contraceptive compositions and methods of use | Chemistry; Metallurgy | 21 | Active |
| US9975896B2 | Inhibitors of transcription factors and uses thereof | Emerging Cross-Sectional Technologies | 15 | Active |
| US9789120B2 | Male contraceptive compositions and methods of use | Chemistry; Metallurgy | 15 | Active |
| US9695172B2 | Diazepane derivatives and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US10407441B2 | Compositions and methods for treating neoplasia, inflammatory disease and other disorders | Emerging Cross-Sectional Technologies | 9 | Active |
| US10150756B2 | Diaminopyrimidine benzenesulfone derivatives and uses thereof | Chemistry; Metallurgy | 9 | Active |
| US10793571B2 | Uses of diazepane derivatives | Human Necessities | 2 | Active |
| US11306105B2 | Cyano thienotriazolodiazepines and uses thereof | Human Necessities | 2 | Active |
| US10881668B2 | Acetamide thienotriazolodiazepines and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10464897B2 | Compounds and methods for treating cancer | Chemistry; Metallurgy | 2 | Active |
| US11731967B2 | Inhibitors of TRIM33 and methods of use | Chemistry; Metallurgy | 1 | Active |
| US10980808B2 | Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies | Human Necessities | 1 | Active |
| US11634450B2 | DOT1L degraders and uses thereof | Human Necessities | 1 | Active |
| US10934256B2 | Compounds and methods for treating cancer | Chemistry; Metallurgy | 1 | Active |
| US10913752B2 | Bivalent bromodomain inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US10633371B2 | EZH2 inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9535067B2 | DOT1L probes | Physics | 0 | Active |
| US12428412B2 | Acetylation writer inhibitor development and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11845728B2 | Compounds and methods for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US11236082B2 | EZH2 inhibitors and uses thereof | Physics | 0 | Active |
| US10730860B2 | Diaminopyrimidine benzenesulfone derivatives and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11406645B2 | Acetamide thienotriazolodiazepines and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.